About
Sir Andrew Philip Witty has been the Chief Executive Officer and Non-Independent Director of UnitedHealth Group Incorporated since February 3, 2021 and served as its Group President since November 2019 until February 3, 2021. Sir Witty served as the Chief Executive Officer at Optum, Inc. since July 1, 2018 until, 2021. He served as Advisor at Eight Partners VC, LLC till 2021. Sir Witty is an Advisor at Hatteras Venture Advisors VI, LLC (formerly known as Hatteras Venture Partners) since January 2020 and he served as Venture Partner at the firm from September 19, 2017. He is an Advisor to the Bill and Melinda Gates Foundation. He served as an Executive Vice President and Member of the Office of the Chief Executive at UnitedHealth Group Incorporated from 2018 to November 2019. He has been Chancellor of the University of Nottingham since January 2013 and was appointed to the UK Business Ambassador Group in January 2014. He served as the Chief Executive Officer of Gsk Plc from May 2008 to March 2017. He had been the Chief Executive Officer of GlaxoSmithKline S.A.E. since May 21, 2008 until March 2017. Sir Witty served as the Chief Executive Officer of GlaxoSmithKline Australia Pty. Ltd. He served as the Chief Executive Officer of GlaxoSmithKline plc from May 21, 2008 to March 31, 2017.
He served as the President of Pharmaceuticals Europe at GlaxoSmithKline Plc since January 2003 and served as its Chief Executive Officer Designate since October 2007. He served as an Executive Director of GlaxoSmithKline plc from January 31, 2008 to March 31, 2017. He served as the Chief Executive Officer of GlaxoSmithKline Consumer Nigeria plc. Since 2003, he served as the President of GSK Europe and joined GSK?s Corporate Executive Team in 1985. He served as the President of the European Federation of Pharmaceutical Industries and Associations until June 2013. He served as a Senior Vice President of Asia Pacific at Pharmaceuticals International since January 2001 and was responsible for its operations in Asia Pacific. He joined Glaxo UK in 1985 and has served in various senior roles in the UK, the U.S., South Africa and Singapore, including Director of Pharmacy & Distribution in Glaxo Pharmaceuticals UK, Director of Business Development of Biocompatibles Limited and International Product Manager of Glaxo Holdings PLC. He served as the Managing Director of Glaxo South Africa and Area Director of South and East Africa.
He served as a Vice President and General Manager at Marketing of Glaxo Wellcome Inc. He served as an Economic Adviser to the Governor of Guangzhou, China from 2000 to 2002. He had been an Independent Director of G1 Therapeutics, Inc. since July 13, 2017. He has been an Independent Director GlaxoSmithKline Group since January 2008. He serves on Imperial College Commercialisation Advisory Board. He serves as a Director of the Office for Strategic Coordination of Health Research. He has been a Member of Advisory Board of Synthego Corp. since September 2017. He was a Member of the UK Prime Minister?s Business Advisory Group and Member of the Global Health Innovation Advisory Board, Imperial College London Group from 2010 until 2015. In 2012. He served as the Lead Non-Executive Board Member at Department for Business, Energy and Industrial Strategy from January 1, 2011 to December 2013. In May 2016, he also served as an advisor to the UK Government COVID Vaccine Taskforce. Mr. Witty became a visiting professor at the Institute of Global Health Innovation at Imperial College, London. He served as a Director of Singapore Economic Development Board. He served as a Director of the Singapore Land Authority Board under the Ministry of Law from 2002 to 2003. He was Director of UnitedHealth Group Incorporated from August 2017 to March 2018. In 2003, he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star. In
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| UnitedHealth Group | Board | Member | 03/02/2021 |